You
AT

Adaptimmune Therapeutics PLC

Company · Health · X0
Statements1
Sightings1
Years covered2025 – now
Primary sourceSEC Form 10-K
All statements
2025 – nowCurrentOur mission is to revolutionize the treatment of solid tumors with a single dose of engineered TCR T-cells and as a result to address cancers with high unmet needs.Mission · Innovation · SEC Form 10-K, filed 2025-03-24
Organization
Type
Company
Industry
Health
Location
X0, US
Size
—
Website
—
Status
active
All filings on SEC EDGAR ↗